Patients with ulcerative colitis in clinical remission are increasingly undergoing colonoscopies to determine endoscopic remission. However, the histological evaluation of biopsy samples provides additional criteria to predict which patients are most likely to undergo relapse, so what is the ideal therapeutic end point for patients with ulcerative colitis?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis
Scientific Reports Open Access 05 September 2019
-
Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study
Scientific Reports Open Access 28 July 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zenlea, T. et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study. Am. J. Gastroenterol. 111, 685–690 (2016).
Bryant, R. V. et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 65, 408–414 (2016).
Park, S., Abdi, T., Gentry, M. & Laine, L. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am. J. Gastroenterol. http://dx.doi.org/10.1038/ajg.2016.418 (2016).
Arijs, I. et al. Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC. Gut http://dx.doi.org/10.1136/gutjnl-2016-312293 (2016).
Thomas, S. & Baumgart, D. C. Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Inflammopharmacology 20, 1–18 (2012).
Geboes, K. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404–409 (2000).
Korelitz, B. I. et al. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. World J. Gastroenterol. 20, 4980–4986 (2014).
Marchal Bressenot, A. et al. Review article: the histological assessment of disease activity in ulcerative colitis. Aliment. Pharmacol. Ther. 42, 957–967 (2015).
Bryant, R. V., Winer, S., Travis, S. P. & Riddell, R. H. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. J. Crohns Colitis 8, 1582–1597 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Riddell, R. Mucosal healing in ulcerative colitis: what constitutes remission?. Nat Rev Gastroenterol Hepatol 14, 5–6 (2017). https://doi.org/10.1038/nrgastro.2016.194
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2016.194
This article is cited by
-
Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis
Scientific Reports (2019)
-
Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study
Scientific Reports (2017)
